Takeda set to move from Deerfield Illinois, 1000 jobs affected

pharmafile | September 12, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois 

Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its Shire Plc acquisition. The company is set to move operations to the greater Boston area, a move that will affect an estimated 1000 workers.

The Deerfield site employs around one fifth of Takeda’s 5000 US employees. Thus although a proportion of those workers affected will be provided with job offers and the chance of relocation, the move is set to cause significant disruption. The company did not provide details as to what percentage of workers will lose their jobs.

The move has come after Takeda was acquired by the Dublin headquartered and London Listed pharma company Shire for £45.3 billion. Meanwhile the acquisition has caused discontent within the Takeda family with company heir Kazu Takeda.

Kazu Takeda said to British newspaper The Times: “We understand that scaling up is necessary, but Takeda management has to think about the traditional corporate culture and the health of the company. Hasty decisions on big deals should be avoided. It will lead to disaster if there are large-scale mergers and acquisitions without careful consideration”

Meanwhile commenting on the move from Deerfield a spokersperson for Takeda’s US operations said:“This move, while difficult, will allow closer collaboration across Takeda to best position our future pipeline for success. It will also simplify our existing Takeda U.S. operations.”

Louis Goss

Related Content

robina-weermeijer-ihfopazzjhm-unsplash_5

MHRA approves Takeda’s Hyqvia for chronic inflammatory demyelinating polyneuropathy treatment

Takeda has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing …

Takeda and ImmunoGen collaborate for development and commercialisation of Elahere in Japan

ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company …

Takeda and HUTCHMED’s cancer drug shown to prolong overall survival

Clinical trial data from a study into the metastatic colorectal cancer (CRC) drug fruquintinib, which …

Latest content